Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis

Clinical trial NCT00587691 · COMPLETED

Trial details

NCT number: NCT00587691
Sponsor: Opexa Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis, Secondary Progressive

Start date: 2002-07-01
Primary completion: 2007-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.